| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| CDMO业务(元) | 523,612,852.73 | 1,033,790,319.64 | 560,377,930.18 | 966,951,633.62 | 395,380,617.98 |
| 肝素钠(原料药)(元) | 452,316,621.69 | 1,069,311,038.42 | 747,769,178.46 | 1,307,761,166.49 | 698,477,390.14 |
| 肝素钠制剂(元) | 1,776,729,260.83 | 2,986,074,622.21 | 1,453,516,215.94 | 2,979,072,285.05 | 1,547,354,298.06 |
| 其他(元) | 64,688,436.92 | 191,537,430.53 | 75,737,582.29 | 191,786,974.96 | 71,687,085.89 |
| 营业成本(元) | |||||
| CDMO业务(元) | 332,086,591.47 | 663,338,983.47 | 385,815,055.84 | 753,916,479.25 | 323,198,665.66 |
| 肝素钠(原料药)(元) | 344,586,251.82 | 755,327,583.29 | 475,225,879.55 | 1,036,999,504.83 | 529,529,023.21 |
| 肝素钠制剂(元) | 1,225,137,748.01 | 1,982,620,666.75 | 933,261,498.13 | 1,680,919,628.19 | 845,872,336.34 |
| 其他(元) | 37,547,499.98 | 123,271,013.59 | 54,842,815.23 | 173,433,136.03 | 58,286,818.06 |
| 毛利(元) | |||||
| CDMO业务(元) | 191,526,261.26 | 370,451,336.17 | 174,562,874.34 | 213,035,154.37 | 72,181,952.32 |
| 肝素钠(原料药)(元) | 107,730,369.87 | 313,983,455.13 | 272,543,298.91 | 270,761,661.66 | 168,948,366.93 |
| 肝素钠制剂(元) | 551,591,512.82 | 1,003,453,955.46 | 520,254,717.81 | 1,298,152,656.86 | 701,481,961.72 |
| 其他(元) | 27,140,936.94 | 68,266,416.94 | 20,894,767.06 | 18,353,838.93 | 13,400,267.83 |
| 毛利率(%) | |||||
| CDMO业务(%) | 36.58 | 35.83 | 31.15 | 22.03 | 18.26 |
| 肝素钠(原料药)(%) | 23.82 | 29.36 | 36.45 | 20.70 | 24.19 |
| 肝素钠制剂(%) | 31.05 | 33.60 | 35.79 | 43.58 | 45.33 |
| 其他(%) | 41.96 | 35.64 | 27.59 | 9.57 | 18.69 |
| 收入构成(%) | |||||
| CDMO业务(%) | 18.59 | 19.58 | 19.75 | 17.76 | 14.57 |
| 肝素钠(原料药)(%) | 16.05 | 20.25 | 26.35 | 24.02 | 25.75 |
| 肝素钠制剂(%) | 63.06 | 56.55 | 51.23 | 54.71 | 57.04 |
| 其他(%) | 2.30 | 3.63 | 2.67 | 3.52 | 2.64 |
| 毛利构成(%) | |||||
| CDMO业务(%) | 21.81 | 21.09 | 17.66 | 11.83 | 7.55 |
| 肝素钠(原料药)(%) | 12.27 | 17.88 | 27.58 | 15.04 | 17.67 |
| 肝素钠制剂(%) | 62.82 | 57.14 | 52.64 | 72.11 | 73.38 |
| 其他(%) | 3.09 | 3.89 | 2.11 | 1.02 | 1.40 |